18F-Fluciclovine PET to Distinguish Tumor Progression From Radiation Necrosis

NCT03930173 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Secondary Malignant Neoplasm of Brain and Cerebral Meninges

Interventions

DRUG: 18F-fluciclovine
DEVICE: PET/CT of the brain

Sponsor

Case Comprehensive Cancer Center